Abstract
Compounds that inactivate lipopolysaccharide (LPS) activity have the potential of being new anti-inflammatory agents. Therefore, we searched among microbial secondary metabolites for compounds that inhibited LPS-stimulated adhesion between human umbilical vein endothelial cells (HUVEC) and HL-60 cells. By this screening, we found a cyclic lipopeptide surfactin from the culture broth of Bacillus sp. BML752-121F2 to be inhibitory. The addition of the surfactin prior to the LPS stimulation decreased HL-60 cell-HUVEC adhesion without showing any cytotoxicity. We confirmed that surfactin inhibited LPS-induced expression of ICAM-1 and VCAM-1 in HUVEC. It also inhibited the cellular adhesion induced by lipid A, the active component of LPS; but it did not inhibit TNF-α or IL-1β-induced cell adhesion. Then, surfactin was shown to suppress the interaction of lipid A with LPS-binding protein (LBP) that mediates the transport of LPS to its receptors. Finally, surface plasmon resonance (SPR) analysis revealed the surfactin to interact reversibly with lipid A. Thus, this Bacillus surfactin was shown to be an inhibitor of LPS-induced signal transduction, directly interacting with LPS.
Similar content being viewed by others
Article PDF
References
Raetz CR, Whitfield C . Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635–700 ( 2002)
Galanos C, Luderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg M, Schade U, Imoto M, Yoshimura H, Kusumoto S, Shiba T . Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 148: 1–5 ( 1985)
Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F . Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274: 10689–10692 ( 1999)
Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B . Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088 ( 1998)
Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D . Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615–625 ( 1999)
Hardaway RM . Traumatic shock alias posttrauma critical illness. Am Surg 66: 284–290 ( 2000)
Cohen J . The immunopathogenesis of sepsis. Nature 420: 885–891 ( 2002)
Jersmann HP, Hii CS, Ferrante JV, Ferrante A . Bacterial lipopolysaccharide and tumor necrosis factor a synergistically increase expression of human endothelial adhesion molecules through activation of NF-κB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 69: 1273–1279 ( 2001)
Stad RK, Buurman WA . Current views on structure and function of endothelial adhesion molecules. Cell Adhes Commun 2: 261–268 ( 1994)
van de Stolpe A, van der Saag PT . Intercellular adhesion molecule-1. J Mol Med 74: 13–33 ( 1996)
Rice GE, Munro JM, Bevilacqua MP . Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med 171: 1369–1374 ( 1990)
Tedder TF, Steeber DA, Chen A, Engel P . The selectins: vascular adhesion molecules. FASEB J 9: 866–873 ( 1995)
Risau W . Differentiation of endothelium. FASEB J 9: 926–933 ( 1995)
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603–606 ( 2001)
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G . Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599–603 ( 2001)
Holt SC, Kesavalu L, Walker S, Genco CA . Virulence factors of Porphyromonas gingivalis. Periodontol 20: 168–238 ( 2000)
Haffajee AD, Socransky SS . Microbial etiological agents of destructive periodontal diseases. Periodontol 5: 78–111 ( 2000)
Ohno O, Ikeda Y, Sawa R, Igarashi M, Kinoshita N, Suzuki Y, Miyake K, Umezawa K . Isolation of heptadepsin, a novel bacterial cyclic depsipeptide that inhibits lipopolysaccharide activity. Chem Biol 11: 1059–1070 ( 2004)
Sano H, Sohma H, Muta T, Nomura S, Voelker DR, Kuroki Y . Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 163: 387–395 ( 1999)
Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D . Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells. J Immunol 167: 3329–3338 ( 2001)
Zhu Y, Ho B, Ding JL . Sequence and structural diversity in endotoxin-binding dodecapeptides. Biochim Biophys Acta 1611: 234–242 ( 2003)
Moore RA, Bates NC, Hancock RE . Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother 29: 496–500 ( 1986)
Cooper DG, Zajic JE . Surface active compounds from microorganisms. Adv Appl Microbiol 26: 229–253 ( 1980)
Arima K, Kakinuma A, Tamura G . Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commun 31: 488–494 ( 1968)
Peypoux F, Bonmatin JM, Wallach J . Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol 51: 553–563 ( 1999)
Nakano MM, Zuber P . Molecular biology of antibiotic production in Bacillus. Crit Rev Biotechnol 10: 223–240 ( 1990)
Kim K, Jung SY, Lee DK, Jung JK, Park JK, Kim DK, Lee CH . Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2 . Biochem Pharmacol 55: 975–985 ( 1998)
Kikuchi T, Hasumi K . Enhancement of reciprocal activation of prourokinase and plasminogen by the bacterial lipopeptide surfactins and iturin Cs. J Antibiot 56: 34–37 ( 2003)
Kikuchi T, Hasumi K . Enhancement of plasminogen activation by surfactin C: augmentation of fibrinolysis in vitro and in vivo. Biochim Biophys Acta 1596: 234–245 ( 2002)
Yokote K, Morisaki N, Zenibayashi M, Ueda S, Kanzaki T, Saito Y, Yoshida S . The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules. Eur J Biochem 217: 723–729 ( 1993)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, T., Ohno, O., Ikeda, Y. et al. Inhibition of Lipopolysaccharide Activity by a Bacterial Cyclic Lipopeptide Surfactin. J Antibiot 59, 35–43 (2006). https://doi.org/10.1038/ja.2006.6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2006.6
Keywords
This article is cited by
-
Mustard seed–associated endophytes suppress Sclerotinia sclerotiorum causing Sclerotinia rot in mustard crop
International Microbiology (2022)
-
Biosurfactants: the next generation biomolecules for diverse applications
Environmental Sustainability (2020)
-
Evaluation of Bacillus subtilis SPB1 Lipopeptide Biosurfactant Toxicity Towards Mice
International Journal of Peptide Research and Therapeutics (2014)